Quality of life, physical functioning, and psychosocial function among patients with achondroplasia: a targeted literature review

Constantinos Constantinidesa BioMarin Europe Ltd., London, UKView further author information

Sarah H. Landisa BioMarin Europe Ltd., London, UKCorrespondence[email protected]

https://orcid.org/0000-0001-9617-3958 View further author information

James Jarretta BioMarin Europe Ltd., London, UKView further author information

Jennifer Quinna BioMarin Europe Ltd., London, UKView further author information

Penelope J. Irelandb Children’s Health Queensland Hospital & Health Service, Brisbane, AustraliaView further author information

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (6)

Sinead NiMhurchadha, Karen Butler, Rob Argent, Katja Palm, Genevieve Baujat, Valerie Cormier-Daire & Klaus Mohnike. (2023) Parents’ Experience of Administering Vosoritide: A Daily Injectable for Children with Achondroplasia. Advances in Therapy 40:5, pages 2457-2470.
Crossref

Mohamad Maghnie, Oliver Semler, Encarna Guillen-Navarro, Angelo Selicorni, Karen E. Heath, Gabriele Haeusler, Lars Hagenäs, Andrea Merker, Antonio Leiva-Gea, Vanesa López González, Adalbert Raimann, Mirko Rehberg, Fernando Santos-Simarro, Diana-Alexandra Ertl, Pernille Axél Gregersen, Roberta Onesimo, Erik Landfeldt, James Jarrett, Jennifer Quinn, Richard Rowell, Jeanne Pimenta, Shelda Cohen, Thomas Butt, Renée Shediac, Swati Mukherjee & Klaus Mohnike. (2023) Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study. Orphanet Journal of Rare Diseases 18:1.
Crossref

Ravi Savarirayan, Wagner Baratela, Thomas Butt, Valérie Cormier-Daire, Melita Irving, Bradley S. Miller, Klaus Mohnike, Keiichi Ozono, Ron Rosenfeld, Angelo Selicorni, Dominic Thompson, Klane K. White, Michael Wright & Svein O. Fredwall. (2022) Literature review and expert opinion on the impact of achondroplasia on medical complications and health-related quality of life and expectations for long-term impact of vosoritide: a modified Delphi study. Orphanet Journal of Rare Diseases 17:1.
Crossref

Young-A Heo. (2022) Vosoritide in achondroplasia: a profile of its use. Drugs & Therapy Perspectives 38:10, pages 417-422.
Crossref

Javier Alonso-Hernández, María Galán-Olleros, Carlos Miranda-Gorozarri, Rosa M. Egea-Gámez & Ángel Palazón-Quevedo. (2022) Two-stage Bone Lengthening With Reuse of a Single Intramedullary Telescopic Nail in Patients With Achondroplasia. Journal of Pediatric Orthopaedics 42:6, pages e616-e622.
Crossref

Miguel Jacinto, Rui Matos, Inês Alves, Carolina Lemos, Diogo Monteiro, Pedro Morouço & Raul Antunes. (2022) Physical Activity, Exercise, and Sports in Individuals with Skeletal Dysplasia: What Is Known about Their Benefits?. Sustainability 14:8, pages 4487.
Crossref

Quality of life, physical functioning, and psychosocial function among patients with achondroplasia: a targeted literature review

Articles from other publishers (6)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Quality of life, physical functioning, and psychosocial function among patients with achondroplasia: a targeted literature review

Citations (6)

Articles from other publishers (6)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date